AILBRY - Article Search
Serach over 250 million academic articles from all areas of study
Results for 'Metastatic Urothelial Carcinoma'
:
Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial
Publication Year: 2016
DOI: https://doi.org/10.1016/s0140-6736(16)00561-4
Abstract:
Add to Library
Authors:
Jonathan E. Rosenberg
Jean H. Hoffman-Censits
Tom Powles
Michiel S. van der Heijden
Arjun Vasant Balar
Andrea Necchi
Nancy A. Dawson
Peter H. O’Donnell
Ani Sarkis Balmanoukian
Yohann Loriot
Sandy Srinivas
Margitta Retz
Petros Grivas
Richard W. Joseph
Matthew D. Galsky
Mark T. Fleming
Daniel P. Petrylak
Jose Luis Pérez‐Gracia
Howard A. Burris
Daniel Castellano
Christina Canil
Joaquim Bellmunt
Dean F. Bajorin
Dorothee Nickles
Richard Bourgon
Garrett M. Frampton
Na Cui
Sanjeev Mariathasan
Oyewale O. Abidoye
Gregg Fine
Robert Dreicer
Erdafitinib in Locally Advanced or Metastatic Urothelial Carcinoma
Publication Year: 2019
DOI: https://doi.org/10.1056/nejmoa1817323
Abstract:
Add to Library
Authors:
Yohann Loriot
Andrea Necchi
Se Hoon Park
Jesús García-Donás
Robert Huddart
Earle F. Burgess
Mark T. Fleming
Arash Rezazadeh
Begoña Mellado
Sergey Varlamov
Monika Joshi
Ignacio Durán
Scott T. Tagawa
Yousef Zakharia
Bob Zhong
Kim Stuyckens
Ademi Santiago-Walker
Peter De Porre
Anne O’Hagan
Anjali Narayan Avadhani
Arlene O. Siefker‐Radtke
Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma
Publication Year: 2020
DOI: https://doi.org/10.1056/nejmoa2002788
Abstract:
Add to Library
Authors:
Thomas Powles
Se Hoon Park
Éric Voog
Claudia Caserta
Begoña P. Valderrama
Howard Gurney
Haralabos P. Kalofonos
Siniša Radulović
Wim Demey
Anders Ullén
Yohann Loriot
Srikala S. Sridhar
Norihiko Tsuchiya
Evgeny Kopyltsov
Cora N. Sternberg
Joaquim Bellmunt
Jeanny B. Aragon‐Ching
Daniel P. Petrylak
Robert J Laliberte
Jing Wang
Bo Huang
Craig B. Davis
Camilla Fowst
Nuno Costa
John A. Blake-Haskins
Alessandra di Pietro
Petros Grivas
Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial
Publication Year: 2016
DOI: https://doi.org/10.1016/s0140-6736(16)32455-2
Abstract:
Add to Library
Authors:
Arjun Vasant Balar
Matthew D. Galsky
Jonathan E. Rosenberg
Thomas Powles
Daniel P. Petrylak
Joaquim Bellmunt
Yohann Loriot
Andrea Necchi
Jean H. Hoffman-Censits
Jose Luis Pérez‐Gracia
Nancy A. Dawson
Michiel S. van der Heijden
Robert Dreicer
Sandy Srinivas
Margitta Retz
Richard W. Joseph
Alexandra Drakaki
Ulka N. Vaishampayan
Srikala S. Sridhar
David I. Quinn
Ignacio Durán
David R. Shaffer
Bernhard J. Eigl
Petros Grivas
Evan Y. Yu
Shi Li
Edward E. Kadel
Zachary Boyd
Richard Bourgon
Priti S. Hegde
Sanjeev Mariathasan
AnnChristine Thåström
Oyewale O. Abidoye
Gregg Fine
Dean F. Bajorin
Efficacy and Safety of Durvalumab in Locally Advanced or Metastatic Urothelial Carcinoma
Publication Year: 2017
DOI: https://doi.org/10.1001/jamaoncol.2017.2411
Abstract:
Add to Library
Authors:
Thomas Powles
Peter H. O’Donnell
Christophe Massard
Hendrik-Tobias Arkenau
Terence W. Friedlander
Christopher Hoimes
Jae‐Lyun Lee
Michael Ong
Srikala S. Sridhar
Nicholas J. Vogelzang
Mayer Fishman
Jingsong Zhang
Sandy Srinivas
Jigar Parikh
Joyce Antal
Xiaoping Jin
Ashok Gupta
Yong Ben
Noah M. Hahn
Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial
Publication Year: 2017
DOI: https://doi.org/10.1016/s1470-2045(17)30065-7
Abstract:
Add to Library
Authors:
Padmanee Sharma
Margitta Retz
Arlene O. Siefker‐Radtke
Ari David Baron
Andrea Necchi
Jens Bedke
Elizabeth R. Plimack
Daniel A. Vaena
Marc‐Oliver Grimm
Sergio Bracarda
José Ángel Arranz
Sumanta K. Pal
Chikara Οhyama
Abdel Saci
Xiaotao Qu
Alexandre Lambert
Suba Krishnan
Alex Azrilevich
Matthew D. Galsky
A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study.
Publication Year: 1992
DOI: https://doi.org/10.1200/jco.1992.10.7.1066
Abstract:
Add to Library
Authors:
Patrick J. Loehrer
Lawrence H. Einhorn
Paul Elson
Emily Crawford
Philip Kuebler
Ian F. Tannock
Derek Raghavan
R. Stuart‐Harris
Michael F. Sarosdy
B A Lowe
Atezolizumab versus chemotherapy in patients with platinum-treated locally advanced or metastatic urothelial carcinoma (IMvigor211): a multicentre, open-label, phase 3 randomised controlled trial
Publication Year: 2017
DOI: https://doi.org/10.1016/s0140-6736(17)33297-x
Abstract:
Add to Library
Authors:
Thomas Powles
Ignacio Durán
Michiel S. van der Heijden
Yohann Loriot
Nicholas J. Vogelzang
Ugo De Giorgi
Stéphane Oudard
Margitta Retz
Daniel Castellano
Aristotelis Bamias
Aude Fléchon
Gwénaëlle Gravis
Syed A. Hussain
Toshimi Takano
Ning Leng
Edward E. Kadel
Romain Banchereau
Priti S. Hegde
Sanjeev Mariathasan
Na Cui
Xiaodong Shen
Christina Louise Derleth
Marjorie C. Green
Alain Ravaud
Avelumab, an Anti–Programmed Death-Ligand 1 Antibody, In Patients With Refractory Metastatic Urothelial Carcinoma: Results From a Multicenter, Phase Ib Study
Publication Year: 2017
DOI: https://doi.org/10.1200/jco.2016.71.6795
Abstract:
Add to Library
Authors:
Andrea B. Apolo
Jeffrey R. Infante
Ani Sarkis Balmanoukian
Manish R. Patel
Ding Wang
Karen Kelly
Anthony Mega
Carolyn D. Britten
Alain Ravaud
Alain C. Mita
Howard Safran
Thomas E. Stinchcombe
Marko Srdanov
Arnold B. Gelb
Michael Schlichting
Kevin M. Chin
James L. Gulley
Nivolumab monotherapy in recurrent metastatic urothelial carcinoma (CheckMate 032): a multicentre, open-label, two-stage, multi-arm, phase 1/2 trial
Publication Year: 2016
DOI: https://doi.org/10.1016/s1470-2045(16)30496-x
Abstract:
Add to Library
Authors:
Padmanee Sharma
Margaret K. Callahan
Petri Bono
Joseph W. Kim
Pavlina Spiliopoulou
Emiliano Calvo
Rathi N. Pillai
Patrick A. Ott
Filippo de Braud
Michael A. Morse
Dung T. Le
Dirk Jaeger
Emily Chan
Chris Harbison
Chen-Sheng Lin
Marina Tschaika
Alex Azrilevich
Jonathan E. Rosenberg
A consensus definition of patients with metastatic urothelial carcinoma who are unfit for cisplatin-based chemotherapy
Publication Year: 2011
DOI: https://doi.org/10.1016/s1470-2045(10)70275-8
Abstract:
Add to Library
Authors:
Matthew D. Galsky
Noah M. Hahn
Jonathan E. Rosenberg
Guru Sonpavde
Thomas E. Hutson
William Oh
Robert Dreicer
Nicholas J. Vogelzang
Cora N. Sternberg
Dean F. Bajorin
Joaquim Bellmunt
Long-term follow-up of a phase III intergroup study of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study.
Publication Year: 1997
DOI: https://doi.org/10.1200/jco.1997.15.7.2564
Abstract:
Add to Library
Authors:
Scott Saxman
Kathleen J. Propert
Lawrence H. Einhorn
Emily Crawford
Ian F. Tannock
Derek Raghavan
Patrick J. Loehrer
D L Trump
Avelumab in metastatic urothelial carcinoma after platinum failure (JAVELIN Solid Tumor): pooled results from two expansion cohorts of an open-label, phase 1 trial
Publication Year: 2017
DOI: https://doi.org/10.1016/s1470-2045(17)30900-2
Abstract:
Add to Library
Authors:
Manish R. Patel
John Ellerton
Jeffrey R. Infante
Manish Agrawal
Michael S. Gordon
Raid Aljumaily
Carolyn D. Britten
Luc Dirix
Keun‐Wook Lee
Mathew Taylor
Patrick Schöffski
Ding Wang
Alain Ravaud
Arnold B. Gelb
Junyuan Xiong
Galit Rosen
James L. Gulley
Andrea B. Apolo
Uroplakin III Is a Highly Specific and Moderately Sensitive Immunohistochemical Marker for Primary and Metastatic Urothelial Carcinomas
Publication Year: 2000
DOI: https://doi.org/10.1309/pyqc-17cb-063t-q07j
Abstract:
Add to Library
Authors:
Olaf Kaufmann
Jan Volmerig
Manfred Dietel
TROPHY-U-01: A Phase II Open-Label Study of Sacituzumab Govitecan in Patients With Metastatic Urothelial Carcinoma Progressing After Platinum-Based Chemotherapy and Checkpoint Inhibitors
Publication Year: 2021
DOI: https://doi.org/10.1200/jco.20.03489
Abstract:
Add to Library
Authors:
Scott T. Tagawa
Arjun Vasant Balar
Daniel P. Petrylak
Arash Rezazadeh Kalebasty
Yohann Loriot
Aude Fléchon
Rohit Jain
Neeraj Agarwal
Manojkumar Bupathi
Philippe Barthélémy
Philippe Beuzeboc
Phillip L. Palmbos
Christos E. Kyriakopoulos
Damien Pouessel
Cora N. Sternberg
Quan Hong
Trishna Goswami
Loretta M. Itri
Petros Grivas
Found 33836 results in 0.232 seconds
What is Boolean Searches
Including any of the words AND
, OR
, or NOT
in any of your searches will enable
boolean search. Those words must be UPPERCASE . You can use this in all searches, including using
the search parameter, and using search filters.
This allows you to craft complex queries using those boolean operators along with parentheses and quotation marks.
Surrounding a phrase with quotation marks will search for an exact match of that phrase, after stemming and
stop-word removal (be sure to use double quotation marks — "
). Using parentheses will specify order of
operations for the boolean operators. Words that are not separated by one of the boolean operators will be
interpreted as AND
.
Behind the scenes, the boolean search is using Elasticsearch's query string query on the searchable fields (such as
title, abstract, and fulltext for works; see each individual entity page for specifics about that entity). Wildcard
and fuzzy searches using *
, ?
or ~
are not allowed; these characters will be
removed from any searches. These searches, even when using quotation marks, will go through the same cleaning as
described above, including stemming and removal of stop words.
Example Search
Search for works that mention "elmo"
and "sesame street"
, but not the words
"cookie"
or "monster"
:
"elmo" AND "sesame street" NOT "cookie" NOT "monster"